You are here
- Home
- Drug Products
- All Drug Products
A Single-centre, Double-blind, Double-dummy, Randomised, Placebo Controlled, Four-period Crossover Study in Healthy Male Volunteers, to Assess the Effect on QT/QTc Interval of Single Oral Doses of AZD1981 (200 mg and 2000 mg) Using Moxifloxacin (Avelox®) as a Positive Control
- Disease
- asthma
- Drug Name
- AZD1981
- Generic Name
- AZD1981
- Sponsor
- AstraZeneca
- Drug Status
- In Development
- Phase
- I
- Start Date
- Jan 11, 2011
- Study Name
- D9830C00011
- Study Id
- D9830C00011
- ClinicalTrials.gov ID
- NCT01265641
- Recruiting Status
- Open
- Protocol Status
- Not Available
- Report Status
- Not Available
